Orange Book product · Brand (NDA)
NICORETTE
NICOTINE POLACRILEX
At a glance
May 18, 2009
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 18, 2009
17 yr 4 mo ago
Today
Patent 8940772 expires
Listed drug product patent expiration.
Apr 30, 2029
in 2 yr 11 mo
Patent 8501164 expires
Listed drug product patent expiration.
Jun 14, 2029
in 3 yr
Pharmaceutical detail
Active ingredient
NICOTINE POLACRILEX
Strength
EQ 2MG BASE
Dosage form
TROCHE/LOZENGE
Route
ORAL
TE code
Not listed
Application
NDA 022360
Product number
001
Marketing status
OTC
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2002NICORETTEBrand (NDA)
NDA 021330 · HALEON US HOLDINGS
- 1996NICORETTEBrand (NDA)
NDA 018612 · HALEON US HOLDINGS
- 1996NICORETTEBrand (NDA)
NDA 020066 · HALEON US HOLDINGS
- 2025NICOTINE POLACRILEXGeneric (ANDA)
ANDA 215276 · DR REDDYS LABS SA
- 2022NICOTINE POLACRILEXGeneric (ANDA)
ANDA 214354 · FERTIN PHARMA
- 2022NICOTINE POLACRILEXGeneric (ANDA)
ANDA 215357 · AUROBINDO PHARMA LTD
- 2021NICOTINE POLACRILEXGeneric (ANDA)
ANDA 213266 · AUROBINDO PHARMA
- 2020NICOTINE POLACRILEXGeneric (ANDA)
ANDA 213233 · DR REDDYS LABS SA
- 2020NICOTINE POLACRILEXGeneric (ANDA)
ANDA 212057 · P AND L
- 2020NICOTINE POLACRILEXGeneric (ANDA)
ANDA 212983 · DR REDDYS LABS SA
- 2020NICOTINE POLACRILEXGeneric (ANDA)
ANDA 212796 · DR REDDYS LABS SA
- 2019NICOTINE POLACRILEXGeneric (ANDA)
ANDA 208875 · P AND L
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8940772 | Apr 30, 2029 | in 2 yr 11 mo | Product |
| 8501164 | Jun 14, 2029 | in 3 yr | Product |

